Immunohistochemical absence of CD21 membrane receptor in nasopharyngeal carcinoma cells infected by Epstein-Barr virus in Spanish patients

被引:10
|
作者
Burgos, JS [1 ]
Vera-Sempere, FJ
机构
[1] Univ Autonoma Madrid, Fac Ciencias, CSIC, Ctr Biol Mol Severo Ochoa,CV Lab 203, E-28049 Madrid, Spain
[2] Univ Valencia, Hosp La Fe, Sch Med, Serv Pathol, Valencia, Spain
来源
LARYNGOSCOPE | 2000年 / 110卷 / 12期
关键词
Epstein-Barr virus; nasopharyngeal carcinoma; non-isotopic in situ hybridization; PCR;
D O I
10.1097/00005537-200012000-00020
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis: The aim of this study was to analyze the relevance of the CD21 membrane receptor in nasopharyngeal carcinoma (NPC). CD21 is implicated in the introduction of the Epstein-Barr virus (EBV) genome into epithelial cells and B lymphocytes. Study Design: Immunohistochemical analysis of CD21 in NPC. Methods: Paraffin-embedded samples of NPC of different histological types with demonstrated presence of EBV were analyzed for CD21 expression using immunohistochemistry. Results: We detected EBV by non-isotopic in situ hybridization (NISH) and nested polymerase chain reaction (PCR) in 100% of samples, regardless of histological type, supporting the previous view that all the types of NPC are variants of an EBV-associated malignancy. CD21 was not detected in NPC, and this absence was a typical feature in our data group. Conclusions: The loss of the CD21 membrane receptor could be one of the immunophenotypical changes of the neoplastic cells that occur in the evolution of the NPC malignancy.
引用
收藏
页码:2081 / 2084
页数:4
相关论文
共 50 条
  • [1] The role of the Epstein-Barr Virus receptor CD21 in Multiple Sclerosis
    Toepfner, Nicole
    Cepok, Sabine
    Grummel, Verena
    Hemmer, Bernhard
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 242 (1-2) : 47 - 51
  • [2] CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells
    Smith, Nicholas A.
    Coleman, Carrie B.
    Gewurz, Benjamin E.
    Rochford, Rosemary
    JOURNAL OF VIROLOGY, 2020, 94 (11)
  • [3] Epstein-Barr virus and CD21 expression in gastrointestinal tumors
    Kim, YS
    Paik, SR
    Kim, HK
    Yeom, BW
    Kim, I
    Lee, D
    PATHOLOGY RESEARCH AND PRACTICE, 1998, 194 (10) : 705 - 711
  • [4] Absence of p53 alterations in nasopharyngeal carcinoma Spanish patients with Epstein-Barr virus infection
    Burgos, JS
    VIRUS GENES, 2003, 27 (03) : 263 - 268
  • [5] Epstein-Barr virus infection of human gastric carcinoma cells: Implication of the existence of a new virus receptor different from CD21
    Yoshiyama, H
    Imai, S
    Shimizu, N
    Takada, K
    JOURNAL OF VIROLOGY, 1997, 71 (07) : 5688 - 5691
  • [6] Epstein-Barr virus and nasopharyngeal carcinoma
    Lawrence SYoung
    Christopher WDawson
    Chinese Journal of Cancer, 2014, 33 (12) : 581 - 590
  • [7] THE EPSTEIN-BARR VIRUS AND NASOPHARYNGEAL CARCINOMA
    TARR, KL
    GLASER, R
    MICROBIAL PATHOGENESIS, 1989, 7 (01) : 11 - 14
  • [8] Epstein-Barr virus and nasopharyngeal carcinoma
    Young, Lawrence S.
    Dawson, Christopher W.
    CHINESE JOURNAL OF CANCER, 2014, 33 (12) : 581 - 590
  • [9] ROLE OF THE CD21 ANTIGEN IN LYMPHOCYTE-TRANSFORMATION BY EPSTEIN-BARR VIRUS
    BOYD, AW
    FECONDO, J
    IMMUNOLOGY AND CELL BIOLOGY, 1988, 66 : 159 - 165
  • [10] EXPRESSION OF THE EPSTEIN-BARR VIRUS (EBV) RECEPTOR ON THE SURFACE OF CELLS INFECTED WITH EBV DERIVED FROM NASOPHARYNGEAL CARCINOMA
    TAKIMOTO, T
    UMEDA, R
    ACTA VIROLOGICA, 1989, 33 (04) : 314 - 319